Drug Trial Radar · NCT01462136
PK Study of ACHN-490 Injection in Renally Impaired Subjects
Last checked: Nov 20, 2026Latest source record: Aug 23, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
Sep 2011
Primary completion
Not stated
Sponsor
- Lead sponsor
- Achaogen, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Department of Health and Human Services
- First posted
- Oct 31, 2011
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purposes of this study is to assess the relationship between renal function and pharmacokinetics of ACHN-490 Injection.
Conditions
- Renal Insufficiency
Interventions
ACHN-490 InjectionDrug
7.5 mg/kg single dose administered intravenously over 30 minutes
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite of PharmacokineticsTime frame: 0-96 hours
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.